25 Oct
|
Agilent
|
Montague
Agilent is forming the Advanced Therapeutics (AAT) division, and the Associate Vice President, Business Development in Canada will shape growth across CDMO services, leveraging microbial fermentation, HPAPI, bioreagents, and cell line development to advance partnerships with biotech and pharma clients. Reporting to the VP Commercial, this role drives go-to-market strategies, builds strategic alliances, and expands market presence by connecting service offerings to client needs.
📌 AVP, Business Development (Montague)
🏢 Agilent
📍 Montague